Oculis Holding AG (OCS) Other Operating Expenses (2022 - 2026)
Oculis Holding AG's (OCS) quarterly Other Operating Expenses came in at -$0.0 in Q1 2026, down 100.1% quarter-over-quarter from $0.0 in Q3 2025.
Oculis Holding AG (OCS) Other Operating Expenses (2022 - 2026) Analysis & Trends
Oculis Holding AG's Other Operating Expenses history runs 5 years deep, the most recent figure standing at -$0.0 for Q1 2026.
- On a quarterly basis, Other Operating Expenses changed N/A year-over-year to -$0.0 in Q1 2026; TTM through Mar 2026 was $0.0, a 51100.0% increase from a year earlier, with the FY2024 full-year figure at $0.0, up 100.0% from the prior year.
- Other Operating Expenses declined to -$0.0 in Q1 2026 per OCS's latest filing, from $0.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $2.7 million in Q2 2023 and bottomed at -$35.4 million in Q1 2023.
- The 5-year median for Other Operating Expenses is $0.0 (2022), against an average of -$4.1 million.
- Across the five-year window, Other Operating Expenses soared 7658529219999900.0% in 2023 and slumped 100.0% in 2024, its largest moves.
- Year by year, Other Operating Expenses stood at -$0.0 in 2022, then surged by 3829264610000000.0% to $71325.6 in 2023, then sank by 100.0% to $0.0 in 2024, then soared by 102300.0% to $0.0 in 2025, then plunged by 100.1% to -$0.0 in 2026.
- Per Business Quant, the three latest OCS Other Operating Expenses figures stand at -$0.0 (Q1 2026), $0.0 (Q3 2025), and $0.0 (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Sep 30, 2023 | 71,325.61 |
| Jun 30, 2023 | 2.67 Mn |
| Mar 31, 2023 | -35.38 Mn |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |